BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6440503)

  • 41. Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock.
    Simoons ML; Muskens G; Hugenholtz PG
    Herz; 1983 Feb; 8(1):34-40. PubMed ID: 6832691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effective plasma concentrations of sulmazol (AR-L 115 BS) on haemodynamics in chronic heart failure.
    Renard M; Jacobs P; Mols P; Melot C; Dresse A; Bernard R
    Br J Clin Pharmacol; 1983 Sep; 16(3):313-8. PubMed ID: 6626424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute hemodynamic effects of MDL 19205 in mild congestive heart failure.
    Cottier C; Follath F; Kiowski W; Pfisterer M; Emmenegger H; Burkart F
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):209-12. PubMed ID: 2436000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hemodynamic effects of a new alpha-1 antagonist, AR-C 239 administrated in intravenous bolus, in patients with cardiac insufficiency].
    Colle JP; Hilaire J; Ohayon J; Besse P
    Arch Mal Coeur Vaiss; 1987 Jan; 80(1):84-91. PubMed ID: 3107496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia.
    Thormann J; Schlepper M; Kramer W; Gottwik M; Kindler M
    J Am Coll Cardiol; 1983 Aug; 2(2):332-7. PubMed ID: 6863766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic effects of continuous infusion of AR-C 239 in left ventricular failure.
    Colle JP; Besse P
    Clin Cardiol; 1989 Apr; 12(4):215-20. PubMed ID: 2565776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of the new inotropic drug AR-L 115 BS upon ventricular automaticity in the rat: comparison with ouabain.
    Hernández J; Serrano JS; Romero M; Pérez-Ojeda E
    Arch Farmacol Toxicol; 1985 Dec; 11(3):149-53. PubMed ID: 4096548
    [No Abstract]   [Full Text] [Related]  

  • 49. Hemodynamic and clinical response to three-day infusion of sulmazol (AR-L 115 BS) in severe congestive heart failure.
    Renard M; Jacobs P; Dechamps P; Dresse A; Bernard R
    Chest; 1983 Oct; 84(4):408-13. PubMed ID: 6413136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The interrelation of central hemodynamic and kidney function indices in patients with ischemic heart disease].
    Biletskiĭ SV; Synchuk AN; Gozhenko AI
    Vrach Delo; 1989 Sep; (9):19-21. PubMed ID: 2609612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of the pharmacodynamics and pharmacokinetics of 2-(2,4-dimethoxyphenyl)-Imidazo-(4,5-b)-pyridine hydrochloride (AR-L 57 CL) in man.
    Belz GG; Nübling H; Zimmer A
    Eur J Clin Pharmacol; 1976 Sep; 10(5):319-24. PubMed ID: 976305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute, single, intravenous doses of cibenzoline: an evaluation of safety, tolerance, and hemodynamic effects.
    Humen DP; Lesoway R; Kostuk WJ
    Clin Pharmacol Ther; 1987 May; 41(5):537-45. PubMed ID: 3568538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemodynamic effects of single-dose administration of AR-L 115 BS in patients with coronary artery disease.
    Weikl A; Kohlschütter S; Durst OE; Lang E
    Arzneimittelforschung; 1981; 31(1a):244-7. PubMed ID: 7195232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The hemodynamic effect of AR-L 115 BS, a new positive-inotropic agent, in patients with left ventricular failure.
    Wollschläger H; Drexler H; Löllgen H; Just H
    Arzneimittelforschung; 1981; 31(1a):248-50. PubMed ID: 7195233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study of the acute effect of AR-L 115 BS, a new positive-inotropic agent in patients with exercise-induced heart failure.
    Drexler H; Wollschläger H; Löllgen H; Just H
    Arzneimittelforschung; 1981; 31(1a):259-62. PubMed ID: 7195237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of AR-L 115 BS on hemodynamics and contractility of the heart in cardiac patients.
    Stauch M; Nechwatal W
    Arzneimittelforschung; 1981; 31(1a):267-71. PubMed ID: 7195239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hemodynamic effects of a new positive inotropic agent (AR-L 115 BS) in ischemic and nonischemic myocardiopathies].
    Colle JP; Ohayon J; Ledain L; Besse P
    Arch Mal Coeur Vaiss; 1984 Dec; 77(13):1532-9. PubMed ID: 6440503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure.
    Hauf GF; Bubenheimer P; Roskamm H
    Arzneimittelforschung; 1981; 31(1a):253-6. PubMed ID: 7195235
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.